Skip to main content
Watch Insiders
AQSTHealthcare

Aquestive Therapeutics Inc (AQST) Insider Trading

In the last 90 days, 2 Aquestive Therapeutics Inc (AQST) insiders reported no open-market purchases and 4 sales totaling $378,930. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Daniel BarberPresident and CEOSale25,000$4.22$105,600
Sep 15, 2026Daniel BarberPresident and CEOSale25,000$4.82$120,488
Sep 9, 2026Sherry KorczynskiChief Commercial OfficerSale8,750$5.22$45,675
Aug 17, 2026Daniel BarberPresident and CEOSale25,000$4.29$107,168
Jul 16, 2026Daniel BarberPresident and CEOSale25,000$4.01$100,193
Jun 23, 2026Julie KropDirectorSale25,000$5.02$125,393
Jun 15, 2026Daniel BarberPresident and CEOSale25,000$4.16$104,010
May 15, 2026Daniel BarberPresident and CEOSale8,257$4.29$35,413

Common questions

AQST insider trading FAQ

Are AQST insiders buying or selling?
Over the last 90 days, AQST insiders were net sellers, reporting $0.00 of open-market purchases and $378,930 of sales.
When was the last AQST insider purchase?
No open-market insider purchase of Aquestive Therapeutics Inc stock was reported in the last 90 days.
Where does AQST insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Aquestive Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.